Showing results (5331-5340 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 9, 2002
Design of telomerase inhibitors for the treatment of cancerDonald Cairns, Rosaleen J Anderson, Philip J Perry, et al.Current Pharmaceutical Design|October 9, 2002
Current status and perspectives in the development of camptothecinsFranco Zunino, Sabrina Dallavalleb, Diletta Laccabuea, et al.Current Pharmaceutical Design|October 9, 2002
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonistsRosaria Volpini, Stefano Costanzi, Catia Lambertucci, et al.Current Pharmaceutical Design|October 9, 2002
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?Pier Giovanni Baraldi, Barbara Cacciari, Pier Andrea Borean, et al.Current Pharmaceutical Design|October 9, 2002
P2-pyrimidinergic receptors and their ligandsChrista E MüllerCurrent Pharmaceutical Design|October 9, 2002
Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonistsGünter Lambrecht, Kirsten Braun, MiSusannechelle Damer, et al.Current Pharmaceutical Design|October 9, 2002
Molecular modeling as a tool to investigate molecular recognition in P2Y receptorsStefano Moro, Kenneth A JacobsonCurrent Pharmaceutical Design|August 13, 2002
DNA topoisomerase I from mycobacteria--a potential drug targetV Nagaraja, D Sikder, P JainCurrent Pharmaceutical Design|August 13, 2002
Bisphosphonates as a foundation of drug delivery to boneHasan UludagCurrent Pharmaceutical Design|August 13, 2002
Experience with indium-111 and yttrium-90-labeled somatostatin analogsI Virgolini, T Traub, C Novotny, et al.Pageof 1,008